New Atlas

Gene editing takes a major step toward ending daily cholesterol pills

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Overcoming Barriers In Cell-Based Cancer Therapy

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
Medical Xpress

New route into cells could make gene therapies safer

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders ...

Gene therapy could treat a deadly heart condition that targets young athletes

A University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a ...
CNN

The race is on to turn your body into a GLP-1 factory

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories churning out a protein that is essentially the active ...
Hosted on MSN

Unlocking the secrets of gene therapy delivery: New insights into genome ejection from AAV vectors

A research team at the University of Osaka has unveiled the molecular mechanism behind genome ejection from adeno-associated virus (AAV) vectors, a crucial delivery vehicle in gene therapy. Subscribe ...
Yahoo

FDA meeting gives window into gene therapy field’s angst

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Anyone looking for evidence of genetic medicine’s ...

Ocugen: Why I Don't Read Too Much Into The Selloff On Phase 2 GA Data

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...